| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/1994 | WO1994012876A1 Allergen/inflammatory testing and diagnosis |
| 06/09/1994 | WO1994012650A2 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | WO1994012649A2 Gene therapy for cystic fibrosis |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012517A1 Sequence-specific binding polymers for duplex nucleic acids |
| 06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | WO1994012503A1 Pulmonary hypertension remedy |
| 06/09/1994 | WO1994012500A1 SUBSTITUTED-PHENYL(N,N'-CYCLOALKYL/ALKYL CARBOXAMIDE)-1H/3H-IMIDAZO[4,5-b]PYRIDINE COMPOUNDS AS PAF ANTAGONISTS |
| 06/09/1994 | WO1994012498A1 METHOD OF PREPARING β-CARBOLINES |
| 06/09/1994 | WO1994012494A1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 06/09/1994 | WO1994012488A1 Nitroxy compounds with pharmaceutical properties |
| 06/09/1994 | WO1994012484A1 Novel method for preparing taxane derivatives, novel derivatives thus obtained and compositions containing them |
| 06/09/1994 | WO1994012481A1 Novel isoxazolines as antiinflammatory agents |
| 06/09/1994 | WO1994012478A1 Benzimidazole compounds which inhibit platelet aggregation |
| 06/09/1994 | WO1994012466A1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 06/09/1994 | WO1994012464A1 Protective role of polyamines in modifications of basement membrane macromolecules |
| 06/09/1994 | WO1994012463A1 Nitric esters having a pharmacological activity and process for their preparation |
| 06/09/1994 | WO1994012461A1 Catechol diethers as selective pdeiv inhibitors |
| 06/09/1994 | WO1994012460A1 Process for preparing substantially pure enantiomers of phenylpropionic acids |
| 06/09/1994 | WO1994012217A1 Cyclodextrin and polymer based drug delivery system |
| 06/09/1994 | WO1994012209A1 Malignant cell growth regulation by common acute lymphoblastic leukemia antigen |
| 06/09/1994 | WO1994012200A1 Dry mix formulation for bisphosphonic acids |
| 06/09/1994 | WO1994012198A1 Injectable taxol composition |
| 06/09/1994 | WO1994012195A1 Method and composition for treating psoriasis, seborrheic dermatitis and eczema |
| 06/09/1994 | WO1994012191A1 Pharmaceutical compositions for use in gastrointestinal washes |
| 06/09/1994 | WO1994012190A1 Health and beauty aid compositions |
| 06/09/1994 | WO1994012188A1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 06/09/1994 | WO1994012187A1 Rectal flunisolide compositions for treating inflammatory intestinal disorders |
| 06/09/1994 | WO1994012186A1 Prostaglandin derivative having radioprotective effects |
| 06/09/1994 | WO1994012185A1 Combination of a calcium channel blocker and an antioxydant for treating ischemic diseases |
| 06/09/1994 | WO1994012184A1 Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis |
| 06/09/1994 | WO1994012183A1 Use of thioureleylenes and thiabendazole in autoimmune diseases |
| 06/09/1994 | WO1994012182A1 Agent for preventing and treating disturbances of intestinal mucous membrane |
| 06/09/1994 | WO1994012181A1 Fibrinogen receptor antagonists |
| 06/09/1994 | WO1994012180A1 Cimetidine granules coated with a partially hydrogenated vegetable oil |
| 06/09/1994 | WO1994012178A1 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | WO1994012177A1 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | WO1994012176A1 Use of phenserine to treat cognitive disorders |
| 06/09/1994 | WO1994012175A1 Lipid level depressant containing penicillide compound as active ingredient |
| 06/09/1994 | WO1994012174A1 Diabetes prevention and treatment |
| 06/09/1994 | WO1994012173A1 Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms |
| 06/09/1994 | WO1994012172A1 Methods of killing protozoal parasites |
| 06/09/1994 | WO1994012171A1 Injectable taxane derivative based compositions |
| 06/09/1994 | WO1994012170A2 Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 06/09/1994 | WO1994012169A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 06/09/1994 | WO1994012168A1 Syrup containing n-acetyl-cysteine |
| 06/09/1994 | WO1994012167A1 Pharmaceutical compositions for local use against insect bites and stings |
| 06/09/1994 | WO1994012166A1 Therapeutic agents for the treatment of cachexia |
| 06/09/1994 | WO1994012165A2 Enzyme inhibitors |
| 06/09/1994 | WO1994012164A1 Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
| 06/09/1994 | WO1994012158A1 Controlled release growth hormone containing microspheres |
| 06/09/1994 | WO1994012156A1 Antibiotic formulation and use for drug resistant infections |
| 06/09/1994 | WO1994012155A1 Antibiotic formulation and process |
| 06/09/1994 | WO1994012153A1 A pharmaceutical formulation |
| 06/09/1994 | WO1994012031A1 Injectable composition |
| 06/09/1994 | WO1994012030A1 Injectable composition |
| 06/09/1994 | WO1994008949A3 Metal-oxime chelates for use as radiopharmaceutical agents |
| 06/09/1994 | WO1994004541A3 Protein kinase inhibitors and related compounds combined with taxol |
| 06/09/1994 | WO1994003177A3 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 06/09/1994 | WO1993012093A1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
| 06/09/1994 | EP0638082A4 Macrocyclic immunomodulators. |
| 06/09/1994 | DE4341332A1 4-Alkyl- und 4-Alkenyl-Delta-3-Cephemsulfone 4-alkyl- and 4-alkenyl-3-Delta Cephemsulfone |
| 06/09/1994 | DE4316326C1 High calorie, low osmolarity intravenous nutrient soln. - contains aminoacid(s), carbohydrate(s), fat and electrolytes, is glycerol free and has neutral pH |
| 06/09/1994 | DE4240806A1 Prods for transdermal oestrogen admin - contain 14,17-ethano-1,3,5-oestratriene-3,17-diol |
| 06/09/1994 | DE4240329A1 Topical medicaments for treating ischaemic tissue defects - comprise super-satd aq vitamin=B soln contg divalent metal ions |
| 06/09/1994 | DE4227989A1 Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel Means for transdermal administration containing 3-keto-desogestrel |
| 06/09/1994 | DE3844839C2 Use of imexon as immunosuppressant acting selectively on B cells |
| 06/09/1994 | DE3645254C2 Medicaments against nausea and vomitting |
| 06/09/1994 | CA2592997A1 Pseudo-adenovirus vectors |
| 06/09/1994 | CA2527566A1 Use of phenserine to treat cognitive disorders |
| 06/09/1994 | CA2400368A1 Catechol diethers as selective pde iv inhibitors |
| 06/09/1994 | CA2308082A1 Injectable compostion |
| 06/09/1994 | CA2151032A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | CA2150695A1 Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | CA2150694A1 Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds |
| 06/09/1994 | CA2150554A1 Cyclodextrin and polymer based drug delivery system |
| 06/09/1994 | CA2150550A1 Fibrinogen receptor antagonists |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | CA2149918A1 Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| 06/09/1994 | CA2149884A1 Cimetidine granules coated with a partially hydrogenated vegetable oil |
| 06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | CA2149758A1 New process for preparing taxane derivatives; new derivatives thus obtained and compositions containing them |
| 06/09/1994 | CA2149674A1 Pharmaceutical compositions for use in gastrointestinal washes |
| 06/09/1994 | CA2149640A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 06/09/1994 | CA2149303A1 Method of preparing .beta.-carbolines |
| 06/09/1994 | CA2147472A1 Treatment of ischemic diseases using a calcium channel blocker and an antioxidant |
| 06/09/1994 | CA2144189A1 Prevention of stenosis |
| 06/09/1994 | CA2143190A1 Substituted-phenyl(n,n'-cycloalkyl/alkyl carboxamide)-1h/3h-imidazo¬4,5-b|pyridine compounds as paf antagonists |
| 06/09/1994 | CA2128094A1 Agent for preventing and treating disturbances of intestinal mucous membrane |
| 06/09/1994 | CA2122494A1 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1- benzopyrans |
| 06/09/1994 | CA2110116A1 Substituted benzoic acids |
| 06/09/1994 | CA2107597A1 Iodinated aroyloxy carboxamides |
| 06/09/1994 | CA2102592A1 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/08/1994 | EP0600834A1 Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
| 06/08/1994 | EP0600832A1 Derivatives of diamino benzoic and diamino phthalic acid und their use as protein linase inhibitors |
| 06/08/1994 | EP0600831A1 Phtalazinon derivatives |
| 06/08/1994 | EP0600830A1 Substituted derivatives of diaminophthalimide as protein-tyrosine kinase inhibitors |
| 06/08/1994 | EP0600782A1 C-11 modified pradimicin derivatives |